DK1115725T3 - Tetrahydropyridoethere - Google Patents

Tetrahydropyridoethere

Info

Publication number
DK1115725T3
DK1115725T3 DK99948776T DK99948776T DK1115725T3 DK 1115725 T3 DK1115725 T3 DK 1115725T3 DK 99948776 T DK99948776 T DK 99948776T DK 99948776 T DK99948776 T DK 99948776T DK 1115725 T3 DK1115725 T3 DK 1115725T3
Authority
DK
Denmark
Prior art keywords
tetrahydropyridoethers
naphthyridine
imidazo
methoxyethoxy
tetrahydro
Prior art date
Application number
DK99948776T
Other languages
Danish (da)
English (en)
Inventor
Stefan Postius
Wolfgang-Alexander Simon
Gerhard Grundler
Guido Hanauer
Reinhard Huber
Wolfgang Kromer
Ernst Sturm
Joerg Senn-Bilfinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1115725T3 publication Critical patent/DK1115725T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK99948776T 1998-09-23 1999-09-17 Tetrahydropyridoethere DK1115725T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19843504 1998-09-23
EP98117988 1998-09-23
PCT/EP1999/006899 WO2000017200A1 (en) 1998-09-23 1999-09-17 Tetrahydropyridoethers

Publications (1)

Publication Number Publication Date
DK1115725T3 true DK1115725T3 (da) 2003-06-23

Family

ID=26049024

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99948776T DK1115725T3 (da) 1998-09-23 1999-09-17 Tetrahydropyridoethere

Country Status (31)

Country Link
US (4) US6436953B1 (cs)
EP (1) EP1115725B1 (cs)
JP (1) JP4145492B2 (cs)
KR (1) KR100668400B1 (cs)
CN (2) CN100506821C (cs)
AT (1) ATE231862T1 (cs)
AU (1) AU763463B2 (cs)
BG (1) BG65195B1 (cs)
BR (1) BR9914044A (cs)
CA (1) CA2344251A1 (cs)
CZ (1) CZ292335B6 (cs)
DE (1) DE69905178T2 (cs)
DK (1) DK1115725T3 (cs)
EA (1) EA005377B1 (cs)
EE (1) EE04677B1 (cs)
ES (1) ES2191464T3 (cs)
GE (1) GEP20032926B (cs)
HK (1) HK1038360B (cs)
HR (1) HRP20010224A2 (cs)
HU (1) HUP0102990A3 (cs)
ID (1) ID28896A (cs)
IL (2) IL142063A0 (cs)
NO (1) NO317304B1 (cs)
NZ (1) NZ510610A (cs)
PL (1) PL193616B1 (cs)
PT (1) PT1115725E (cs)
RS (1) RS50145B (cs)
SI (1) SI1115725T1 (cs)
SK (1) SK285165B6 (cs)
TR (1) TR200100805T2 (cs)
WO (1) WO2000017200A1 (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100506821C (zh) 1998-09-23 2009-07-01 奥坦纳医药公司 四氢吡啶醚化合物
SI1173439T1 (en) * 1999-04-17 2003-10-31 Altana Pharma Ag Haloalkoxy imidazonaphthyridines
CA2285516C (en) * 1999-05-12 2010-12-07 President And Fellows Of Harvard College Dopamine transporter imaging agents
CZ20023194A3 (cs) * 2000-03-29 2003-01-15 Altana Pharma Ag Prekursory imidazopyridinových derivátů
IL151198A0 (en) * 2000-03-29 2003-04-10 Altana Pharma Ag Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same
KR20040011423A (ko) * 2000-10-25 2004-02-05 알타나 파마 아게 위액 분비 억제제로서의 다중치환된 이미다조피리딘
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
BR0207762A (pt) * 2001-03-08 2004-06-01 Astrazeneca Ab Uso de um composto ou um sal farmaceuticamente aceitável do mesmo, combinação, formulação farmacêutica, kit, método para a prevenção da úlcera gástrica induzida por medicamento, e, composição farmacêutica oral
ATE336493T1 (de) 2001-08-02 2006-09-15 Altana Pharma Ag Tricyclische epoxide
EP1417208A1 (en) * 2001-08-03 2004-05-12 ALTANA Pharma AG Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases
KR20040023697A (ko) * 2001-08-03 2004-03-18 알타나 파마 아게 위장관계 장애의 치료를 위한 알킬 치환 이미다조피리딘
KR20040081204A (ko) 2002-02-15 2004-09-20 알타나 파마 아게 트리시클릭 n-아실 화합물
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EA200401454A1 (ru) * 2002-05-07 2005-06-30 Алтана Фарма Аг Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
EA008304B1 (ru) 2002-11-19 2007-04-27 Алтана Фарма Аг 8-замещённые имидазопиридины
ES2312844T3 (es) 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
JP2006515848A (ja) * 2002-12-20 2006-06-08 アルタナ ファルマ アクチエンゲゼルシャフト シリルエーテル
WO2004071391A2 (en) * 2003-02-17 2004-08-26 Altana Pharma Ag Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders
JP4742026B2 (ja) 2003-03-10 2011-08-10 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング ロフルミラストの新規の製造方法
TW200503783A (en) * 2003-04-11 2005-02-01 Altana Pharma Ag Oral pharmaceutical preparation for proton pump antagonists
SA04250092B1 (ar) * 2003-05-14 2008-05-04 التانا فاروا ايه جي مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً
CA2526566A1 (en) * 2003-05-27 2004-12-09 Altana Pharma Ag Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
CA2537182A1 (en) * 2003-08-29 2005-03-10 Dynogen Pharmaceuticals, Inc. Compositions useful for treating gastrointestinal motility disorders
CA2538419C (en) 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
CA2544325A1 (en) * 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
CA2549860A1 (en) 2003-12-19 2005-06-30 Altana Pharma Ag Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives
NZ549011A (en) * 2004-02-17 2009-04-30 Altana Pharma Ag Tricyclic imidazopyridines and intermediates for the synthesis thereof
EP1784402B1 (en) 2004-09-03 2011-08-03 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
WO2006038773A1 (en) 2004-09-03 2006-04-13 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-c]피리딘 유도체 및 그의 제조방법
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
EP2080513A1 (en) 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
JP5802898B2 (ja) * 2009-07-09 2015-11-04 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
WO2012027240A1 (en) * 2010-08-23 2012-03-01 Schering Corporation Fused tricyclic inhibitors of mammalian target of rapamycin
JP6001168B2 (ja) * 2012-06-15 2016-10-05 バイオ‐ファーム ソリューションズ カンパニー リミテッドBio‐Pharm Solutions Co., Ltd. フェニルアルキルスルファメート化合物及びこれを含む筋弛緩剤組成物
WO2015052256A1 (en) 2013-10-08 2015-04-16 Katairo Gmbh Tetrahydropyridoethers for the treatment of stargardt's disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468400A (en) * 1982-12-20 1984-08-28 Schering Corporation Antiulcer tricyclic imidazo [1,2-a]pyridines
KR890701585A (ko) 1987-07-16 1989-12-21 헤르베르크 슈키·울리히 볼프 새로운 디아졸
SE9401197D0 (sv) * 1994-04-11 1994-04-11 Astra Ab Active compounds
NZ290819A (en) * 1994-07-28 1998-06-26 Byk Gulden Lomberg Chem Fab Acyl 8-benzyloxy- or 8-benzylaminoimidazopyridines
DK0971922T3 (da) * 1997-03-24 2004-08-16 Altana Pharma Ag Tetrahydropyrido-forbindelser
HUP0001555A3 (en) * 1997-10-30 2001-01-29 Altana Pharma Ag Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
CN100506821C (zh) * 1998-09-23 2009-07-01 奥坦纳医药公司 四氢吡啶醚化合物

Also Published As

Publication number Publication date
NO20011243D0 (no) 2001-03-12
BR9914044A (pt) 2001-12-04
JP4145492B2 (ja) 2008-09-03
EA200100315A1 (ru) 2001-10-22
CZ292335B6 (cs) 2003-09-17
CA2344251A1 (en) 2000-03-30
CZ20011082A3 (cs) 2001-09-12
ATE231862T1 (de) 2003-02-15
US7393860B1 (en) 2008-07-01
NO317304B1 (no) 2004-10-04
CN100506821C (zh) 2009-07-01
HK1038360A1 (en) 2002-03-15
CN1155598C (zh) 2004-06-30
EE04677B1 (et) 2006-08-15
AU6192099A (en) 2000-04-10
EP1115725A1 (en) 2001-07-18
PL346617A1 (en) 2002-02-25
KR100668400B1 (ko) 2007-01-17
US6436953B1 (en) 2002-08-20
NZ510610A (en) 2003-07-25
HK1038360B (en) 2003-05-16
WO2000017200A1 (en) 2000-03-30
US6696460B2 (en) 2004-02-24
CN1560055A (zh) 2005-01-05
IL142063A (en) 2007-10-31
ES2191464T3 (es) 2003-09-01
SK3992001A3 (en) 2001-12-03
SK285165B6 (sk) 2006-07-07
PT1115725E (pt) 2003-06-30
US20040162310A1 (en) 2004-08-19
SI1115725T1 (en) 2003-06-30
HUP0102990A2 (hu) 2002-01-28
YU21401A (sh) 2004-03-12
JP2002526499A (ja) 2002-08-20
CN1319101A (zh) 2001-10-24
PL193616B1 (pl) 2007-02-28
EP1115725B1 (en) 2003-01-29
TR200100805T2 (tr) 2001-08-21
BG105270A (en) 2001-11-30
AU763463B2 (en) 2003-07-24
KR20010075223A (ko) 2001-08-09
HUP0102990A3 (en) 2002-09-30
RS50145B (sr) 2009-03-25
NO20011243L (no) 2001-03-12
IL142063A0 (en) 2002-03-10
US20020169320A1 (en) 2002-11-14
BG65195B1 (bg) 2007-06-29
HRP20010224A2 (en) 2002-04-30
US7105676B2 (en) 2006-09-12
DE69905178D1 (de) 2003-03-06
EE200100172A (et) 2002-06-17
EA005377B1 (ru) 2005-02-24
ID28896A (id) 2001-07-12
GEP20032926B (en) 2003-03-25
DE69905178T2 (de) 2003-07-17

Similar Documents

Publication Publication Date Title
DE69905178D1 (de) Tetrahydropyridoether
EE200000626A (et) Imidasopüridiini derivaadid, mis inhibeerivad maohappesekretsiooni
EE200200183A (et) Meetod polüisobuteenfenooli sisaldavate Mannichi aduktide saamiseks
ZA200108855B (en) Method for the preparation of citalopram.
CY2007029I2 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
ZA200108854B (en) Method for the preparation of citalopram.
NO20011214D0 (no) FremgangsmÕte for fremstilling av aromatiske aldehyder
TR199901597A3 (tr) Kaplanmis peroksijen bilesikleri hazirlama yöntemi.
IS5715A (is) Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni
ZA200106683B (en) Method for the preparation of citalopram.
DE60114617D1 (de) Zolpidem hemitartrat
ZA200206699B (en) Method for the preparation of citalopram.
IT1319251B1 (it) Metodo per la preparazione di 5-carbossiftalide.
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
IT1303759B1 (it) Procedimento migliorato per la preparazione di acido 7-azaindolil-3-carbossilico.
NO996080L (no) FremgangsmÕte for deteksjon, særlig av smÕ sjømÕl
AU5794700A (en) Method for determining the fertility of mammals, especially humans
PT1133495E (pt) Semi-hidrocloreto do acido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-¬4.3.0|-nonano-8-il)-6-fluoro-1,4-diidro-4-oxo-3-quinolinocarboxilico
IT1313660B1 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani.
IT1302262B1 (it) Procedimento per la produzione di estratti di soia
NO20005743D0 (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- oksyglukoronider
EA199900020A2 (ru) Способ получения нафтиридонов и промежуточных соединений
TR199801514A3 (tr) N-Piruvil-L-Prolin üretimi için yöntem.
IS5212A (is) Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu